- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Lumexa Imaging Holdings, Inc. Common Stock(LMRI)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for LMRI
11/13/2026: LMRI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Lumexa Imaging Holdings, Inc. is a healthcare services provider specializing in outpatient diagnostic imaging and professional teleradiology solutions. The company exhibits solid top-line revenue scaling past $1 billion, bolstered by a growing network of strategic health-system joint ventures and its Connexia digital platform. Its primary growth opportunity lies in expanding outpatient footprints and capturing market share in fragmented regional markets. However, investors must weigh ongoing GAAP net losses, capital intensity, and pricing pressures from health insurance payers. This stock suits growth-oriented investors willing to tolerate medium-term operational volatility while monitoring net margin improvements and partnership execution.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Top-line revenue expansion and aggressive joint-venture scaling appeal to capital appreciation strategies. |
| Momentum investor | Strong fit while signal remains positive | Positive analyst consensus and strong upside price momentum create favorable technical setups. |
| Value investor | Weak fit | The company is currently working through historical net losses and trades without a mature P/E multiple profile. |
| Dividend investor | Weak fit | Lumexa does not distribute dividends, retaining capital for business expansion. |
| Low-risk investor | Mixed fit | Operational volatility and healthcare reimbursement risks introduce moderate downside exposure. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | Fluctuations across its 52-week trading range expose short-term holders to swift market swings. |
| Valuation risk | Medium | Valuation relies heavily on projected earnings improvements and sustained joint-venture growth. |
| Competition risk (outpatient and teleradiology competition) | Medium / high | Intense competition from established national chains and hospital networks can pressure margins. |
| Business quality | Medium | Essential healthcare service demand provides a steady baseline, though profitability remains under development. |
| Dividend income | Low / none | Income-focused investors receive no cash return via dividends. |
| Execution risk | Medium / high | Successful integration of new joint ventures and scaling of the Connexia platform are critical to meeting targets. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.42B USD | Price to earnings Ratio - | 1Y Target Price 18.11 |
Price to earnings Ratio - | 1Y Target Price 18.11 | ||
Volume (30-day avg) 377.6K shares | Beta - | 52 Weeks Range 6.45 - 19.45 | Updated Date 11/15/2026 |
52 Weeks Range 6.45 - 19.45 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.26 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Devices
- BUY participation
- 62.5%
- Active BUY / eligible
- 5 / 8
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steady Uptrend
The stock demonstrates consistent and steady upward price momentum.

Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit 35.89% | Avg. Invested days 32 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Outpatient Imaging Centers | Fees collected from patients and insurers for conducting physical diagnostic scans like MRI, CT, and X-ray. | This is the core brick-and-mortar hospital alternative business generating predictable clinical service volume. |
| Professional Services | Contracts with external hospitals and clinics to provide remote and on-site radiologist interpretations. | Provides high-margin B2B professional diagnostic reporting support to third-party medical facilities. |
| Geographic Operations | Multi-state outpatient networks anchored by joint ventures with prominent regional health systems. | Geographic expansion minimizes local economic downturn exposure by diversifying across multiple healthcare markets. |
Earnings Date
Report Date 2026-11-10 | When After Market | Estimate 0.07 | Actual 0.14 |
Profitability
Profit Margin -1.61% | Operating Margin (TTM) 2.56% |
Management Effectiveness
Return on Assets (TTM) 0.96% | Return on Equity (TTM) -4.26% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 2.31B | Price to Sales(TTM) 1.35 |
Enterprise Value 2.31B | Price to Sales(TTM) 1.35 | ||
Enterprise Value to Revenue 2.19 | Enterprise Value to EBITDA 17.77 | Shares Outstanding 96.12M | Shares Floating 22.11M |
Shares Outstanding 96.12M | Shares Floating 22.11M | ||
Percent Insiders 80.76 | Percent Institutions 34.45 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

